New Rhein Healthcare Investors

Venture Capital SEC-registered adviser

Legal name: New Rhein Healthcare Investors LLC

Philadelphia, PA Website

AUM

$290.8M
Regulatory AUM

Private funds

6
Venture Capital 6

Private fund assets

$248.1M
Gross asset value

Employees

10

Last Form D raise

Jan 2025
Most recent fund filing

From SEC Form ADV filing (filed Mar 30, 2026). View on SEC

People(3)

Owners and executive officers named on the firm's SEC Form ADV.

I
Ivan Gergel
Managing Partner & Chief Medical Officer
Source: SEC Form ADV
N
Nayan Parekh
Founder & Managing Partner
Source: SEC Form ADV
S
Subhanu Saxena
Managing Partner & Chief Compliance Officer
Source: SEC Form ADV

Funds(6)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Nrhi Alveus Fund I, LPVenture Capital$9.8M——Jan 2025Cool
New Rhein Healthcare 2021 (lux) ScspVenture Capital$113.7M$104.8M10Sep 2022Cold
New Rhein Healthcare 2021 (de) LPVenture Capital$63.0M$104.8M18Sep 2022Cold
New Rhein Healthcare 18 LPVenture Capital$35.2M$30.1M21Jun 2020Cold
New Rhein Healthcare 18 (parallel) ScspVenture Capital$26.4M——Nov 2018Cold
New Rhein Healthcare 2021 PrivakVenture Capital$67.9M———

Board seats(2)

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

Alveus Therapeutics
PharmaceuticalsPhiladelphia, PADirector: Ivan Gergel
$56.9M raised
Since Jan 2026
SEC Form D
Neuraptive Therapeutics
BiotechnologyPhiladelphia, PADirector: Ivan Gergel
$29.8M raised
Since Apr 2019
SEC Form D

Regulatory identifiers

CRD number
300842
SEC file number
801-124768

Sources